DeCell Technologies Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
DeCell Technologies General Information
Description
Operator of a biotechnology company intended to maintain the natural composition and structure of tissue to stimulate regenerative cell responses. The company's technology specializes in processes of donated human tissue using its patented technology to remove cellular components while leaving the structural matrix of the tissue intact and at the same time deactivates and removes potential bacteria and viruses, producing a sterile, safe and effective biological scaffold that promotes tissue regeneration when implanted into a patient, enabling patients to have improved wound healing and surgical reconstructions.
Contact Information
Website
www.decelltechnologies.comCorporate Office
- 6160 Charles Street
- Halifax, Nova Scotia B3K 1L4
- Canada
Corporate Office
- 6160 Charles Street
- Halifax, Nova Scotia B3K 1L4
- Canada
DeCell Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | 11-Dec-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 01-Dec-2014 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | $550K | Completed | Generating Revenue | |||
| 1. Seed Round | 13-Nov-2013 | $550K | $550K | Completed | Generating Revenue |
DeCell Technologies Comparisons
Industry
Financing
Details
DeCell Technologies Competitors (2)
One of DeCell Technologies’s 2 competitors is Mimedx Group, a Corporation company based in Marietta, GA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mimedx Group | Corporation | Marietta, GA | ||||
| MTF Biologics | Venture Capital-Backed | Edison, NJ |
DeCell Technologies Patents
DeCell Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2791158-A1 | Methods for tissue decellularization | Active | 26-Feb-2010 | ||
| CA-2791158-C | Methods for tissue decellularization | Active | 26-Feb-2010 | ||
| EP-2538988-A2 | Methods for tissue decellularization | Active | 26-Feb-2010 | ||
| EP-2538988-A4 | Methods for tissue decellularization | Active | 26-Feb-2010 | ||
| EP-2538988-B1 | Methods for tissue decellularization | Active | 26-Feb-2010 | A61L27/60 |
DeCell Technologies Signals
DeCell Technologies Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Spring Activator | Accelerator/Incubator |
DeCell Technologies FAQs
-
When was DeCell Technologies founded?
DeCell Technologies was founded in 2012.
-
Where is DeCell Technologies headquartered?
DeCell Technologies is headquartered in Halifax, Canada.
-
What is the size of DeCell Technologies?
DeCell Technologies has 5 total employees.
-
What industry is DeCell Technologies in?
DeCell Technologies’s primary industry is Medical Supplies.
-
Is DeCell Technologies a private or public company?
DeCell Technologies is a Private company.
-
What is DeCell Technologies’s current revenue?
The current revenue for DeCell Technologies is .
-
How much funding has DeCell Technologies raised over time?
DeCell Technologies has raised $800K.
-
Who are DeCell Technologies’s investors?
Spring Activator has invested in DeCell Technologies.
-
Who are DeCell Technologies’s competitors?
Mimedx Group and MTF Biologics are competitors of DeCell Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process